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 ABSTRACT 
 One hundred fifty multiparous cows were balanced 
to 1 of 3 treatments (2 pens/trt) according to previous 
lactation 305-d mature equivalent yield to evaluate sup-
plementation with yeast culture (YC; A-Max, Vi-COR, 
Mason, IA) and YC plus enzymatically hydrolyzed yeast 
(YC+EHY; Celmanax, Vi-COR) on production perfor-
mance in dairy cattle. Cows entered pens at calving and 
remained through 14 wk postpartum. Treatment assign-
ment to pens was random throughout the barn. Pens 
were identical in layout and each contained an exit alley 
to eliminate feed and animal mixing. The 3 treatments 
were control: nonsupplemented; YC: control diet with 
YC (56 g/d); and YC+EHY: control diet plus YC and 
EHY (28 g/d). Mean pen dry matter intake was similar 
across treatments. Cows supplemented with YC and 
YC+EHY produced more milk, fat-corrected milk, and 
energy-corrected milk than control cows (1.4 and 1.6, 
1.6 and 1.8, 1.7 and 1.9 kg, respectively). Treatments 
YC and YC+EHY did not differ. Milk fat and lactose 
percentages were not affected by treatment. Milk pro-
tein percentage was higher for cows supplemented with 
YC+EHY than for those on YC and control treatments 
(2.98, 2.93, and 2.91%, respectively) with control and 
YC-supplemented cows not being different from each 
other. Differences in fat and protein yields were pri-
marily reflective of milk yield. Treatment had no effect 
on milk urea nitrogen. No differences in the incidence 
of metabolic health were observed; however, cases of 
clinical mastitis for YC+EHY were less than half those 
for control and YC during wk 8 to 14 on trial. Somatic 
cell count was higher for cows fed control and YC diets 
compared with YC+EHY, primarily during wk 8 to 
14 on trial. Supplementation of early lactation cows 
with YC improved milk production performance; fur-
thermore, EHY supplementation improved milk protein 
percentage and mammary gland health. 
 Key words:   yeast culture ,  enzymatically hydrolyzed 
yeast ,  milk performance ,  somatic cell 
 INTRODUCTION 
 Yeast culture supplementation in dairy rations is 
efficacious and has been practiced commercially for 
several years (Piva et al., 1993; Swartz et al., 1994; 
Newbold et al., 1995). A recent meta-analysis (Des-
noyers et al., 2009) of 157 experiments demonstrated 
that yeast supplementation increased feed intake, milk 
production, rumen pH, rumen VFA, and organic mat-
ter digestibility. In addition, the effects of yeast were 
enhanced when animals consumed diets with a higher 
proportion of concentrate. Their results also suggested 
that yeast supplementation limited the decrease in 
rumen pH typically associated with increased VFA 
concentration and decreased lactic acid, suggesting an 
enhanced buffering capacity. Positive responses to yeast 
may therefore be to mitigate the negative effects of 
feeding high-concentrate diets (Desnoyers et al., 2009). 
 Sub-therapeutic use of antibiotics has demonstrated 
many benefits in animal production (Ferket, 2003). 
Most economical benefits are associated with increased 
feed conversion, faster rate of growth, and reduced 
mortality. Antibiotics generally work by limiting detri-
mental microorganisms as well as growth and coloniza-
tion of nonpathogenic bacteria. This in turn reduces 
weight and length of intestines, metabolic demands for 
the gastrointestinal system, and overstimulation of the 
host immune system, all of which draw nutrients away 
from optimal performance (Visek, 1978; Klasing, 1988; 
Ferket, 1991). The concern associated with resistant 
strain development through antibiotic use has gener-
ated strong debate and objections to sub-therapeutic 
uses of antibiotic for promoting growth. Whether justi-
fied or not (Gustafson and Bowen, 1997), alternatives 
to antibiotics must be investigated. 
 Mannan oligosaccharide (MOS), a yeast cell wall 
component, can act as a high-affinity ligand offering 
competitive binding site options for gram-negative 
bacteria, which possess mannose-specific type-1 fim-
briae (Ofek et al., 1977). The immediate benefits are 
associated with pathogen removal from the digestive 
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system without attachment and colonization. This 
phenomenon may elicit significant antigenic responses, 
thus enhancing humoral immunity against specific 
pathogens through presentation of the attenuated 
antigens to immune cells (Ballou, 1970; Spring et al., 
2000; Ferket, 2003). In addition, this process may sup-
press the proinflammatory immune response, which 
is detrimental to production performance (Ferket, 
2002). Another predominant yeast cell wall component, 
β-1,3/1,6-glucan (β-glucan), has been shown to exhibit 
immunomodulatory effects when used as a supplement 
in aquatic (Dalmo and Bogwald, 2008), swine (Eicher 
et al., 2006; Li et al., 2006), and avian (Lowry et al., 
2005; Chae et al., 2006) diets.
Few studies have investigated the use of yeast cell 
wall components on immune function in dairy cattle. 
Seymour et al. (1995) reported decreased incidence of 
elevated body temperatures in calves when 1% brewer’s 
yeast was supplemented to a calf starter. Franklin et al. 
(2005) supplemented dry cows with MOS and observed 
enhancement of humoral immune response of cows to 
rotavirus and a tendency for enhanced transfer of ro-
tavirus antibodies to calves. Supplementation of MOS 
in milk replacer improved fecal scores and reduced 
scours in calves to the same extent as antibiotics (Hein-
richs et al., 2003). The therapeutic use of β-glucans 
infused into infected quarters of cows showed no effect 
on chronic subclinical Staphylococcus aureus mastitis; 
however, the proportion of milk lymphocytes tended 
to increase postinfusion (Waller et al., 2003). No stud-
ies have been reported to evaluate the effect of yeast 
culture and yeast culture plus additional yeast cell wall 
preparations on production performance and the inci-
dence of postpartum disease. This study was conducted 
to evaluate supplementation with yeast culture (YC) 
and yeast culture with enzymatically hydrolyzed yeast 
(YC+EHY) on production performance and health in 
dairy cattle.
MATERIALS AND METHODS
Animals, Diets, and Experimental Design
One hundred fifty multiparous cows were balanced to 
1 of 6 treatment pens (experimental unit) according to 
previous lactation 305-d mature equivalent yield. Cows 
were housed in a freestall barn that contained 6 pens 
(70 stalls/pen), 3 on each side of a 6-row barn. Cows 
entered the groups at calving and remained through 14 
wk postpartum. Treatments were randomly assigned to 
each pen per side of barn. Pens were identical in layout 
and each pen contained an exit alley such that cows 
from adjacent pens would not interfere with or have 
access to another pen’s treatment feed when moved 
for milking. Beds were sand-based, and water and feed 
space accessibility was equal in all pens.
The 3 treatments in this study were as follows: (1) 
control: fresh cow diet; (2) yeast culture (YC): control 
diet with the inclusion of A-Max Yeast Culture Con-
centrate (Vi-COR, Mason City, IA) at 56 g/cow per 
day; and (3) yeast culture + enzymatically hydrolyzed 
yeast (YC+EHY): control diet with the inclusion of 
Celmanax (Vi-COR) at 28 g/cow per day.
The basal diets were formulated for requirements of a 
lactating cow at 50 DIM, producing 45 kg of 3.5% FCM 
milk (NRC, 2001); ingredient and nutrient composition 
of the control diet are shown in Tables 1 and 2. As 
cows were assigned to each pen, they were housed with 
nontrial cows of similar DIM to accommodate a one 
cow-one stall environment. Trial animals were identified 
with treatment-specific color-coded ear tags. When the 
first cow entered each treatment pen, treatment diets 
commenced until the last treatment cow was removed.
Measurements
Milk. Cows were milked twice daily (0400 and 1600 
h) in a double-17 parallel milking parlor with sam-
pling devices. Milk production was recorded daily. All 
daily milkings were totaled for each cow within pen on 
study for the same day in lactation. Total daily milks 
were calculated to represent mean daily milk per cow 
for comparative purposes. Milk samples for composi-
tion were collected and composited from each cow at 
p.m. and a.m. milkings (two 50:50, 30-mL aliquots) 
on a weekly basis. Samples were preserved, frozen, 
and thawed slowly after all trial cows in each group 
Table 1. Ingredient composition of experimental diet 
Ingredient
% DM  
basis
Haylage 7.7
Western alfalfa hay 5.8
Corn silage 58.6
Corn meal 10.6
Beet pulp 6.1
Soybean meal 5
Soybean (roasted) 1.8
Dairy premix1 4.3
Treatment premix2 0.1
1Dairy premix: 14.7% corn distillers, 5.1% corn gluten feed, 3.7% fish 
meal, 3.7% blood meal, 12.8% soy plus (West Central Cooperative, 
Ralston, IA), 16% Megalac (Arm and Hammer Nutrition Group, 
Princeton, NJ), 12.8% calcium carbonate, 1.9% magnesium oxide, 
5.7% urea, 3.4% salt, 1.0% tallow, 7.2% sodium bicarbonate, and 12% 
mineral-vitamin mix.
2Treatment premix: control = corn meal fed at the manufacturers 
recommended level in 225 g/cow per day. The premix corn meal was 
subtracted from the diet corn meal total; yeast culture  = A-Max 
Yeast Concentrate (Vi-COR, Mason, IA) at 56 g/cow per day + 169 
g of corn meal; and yeast culture/enzymatically hydrolyzed yeast = 
Celmanax (Vi-COR) at 28 g/cow per day + 197 g of corn meal.
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completed each week. A weekly pen composite sample 
was created based on an average weighted weekly milk 
production per cow. Composite samples were submit-
ted to DairyOne (Ithaca, NY) for analysis of protein, 
fat, lactose, and MUN by Milkoscan (Foss Electric, 
Hillerød, Denmark), and SCC were determined by the 
Fossomatic 5000 (Foss Electric). The equation used for 
FCM was as follows: 3.5% FCM = [0.4255 × milk (lb)] 
+ [16.425 × (fat%/100) × milk (lb)]. Energy-corrected 
milk was calculated as follows: ECM = (kg of milk × 
0.327) + (kg of milk fat × 12.95) + (kg of protein × 
7.2) (Shirley, 2006).
DMI Estimates. Daily group intakes were recorded 
throughout the trial period for each treatment pen. The 
number of total cows represented in a given group re-
mained constant, but did not necessarily represent cows 
entirely on trial. Total feed offered divided by total cows 
in the pen on a given day was calculated. Body weight 
and condition scores (Wildman et al., 1982) were taken 
on all animals at treatment initiation (day of calving) 
and termination from study.
Health. The following health indices were recorded: 
retained placenta (placental membranes retained for 
more than 24 h after calving); metritis (diagnosed by 
a purulent vaginal discharge); ketosis (detected by a 
high urine ketone content with litmus strips); displaced 
abomasums (detected by percussion with a stethoscope 
on either the left or right side of the cow). New clinical 
mastitis cases were detected by the following proce-
dure. At each milking, 3 forestrip ejections of milk from 
each quarter were evaluated for evidence of abnormal 
secretions (flakes, clots, stringy, creamy, watery). If an 
abnormal secretion was observed, persistency was de-
termined by stripping 6 to 8 more ejections. If the ab-
normal secretion persisted after 6 to 8 more ejections, 
the gland quarter was classified as clinical mastitis. A 
new clinical case on the same quarter was not declared 
until the infected quarter was free of abnormal secre-
tion for at least 14 d after the declaration of normal 
saleable milk for that quarter.
Statistical Analysis
Statistical procedures (SAS Institute, 1999) using 
split-plot-in-time ANOVA for repeated measures were 
conducted for parameters that had a period effect; that 
is, milk and composition. The model was as follows: Yijk 
= μ + trti + penj (trti) + weekk + trti × weekk + Eijk, 
where pen was the experimental unit, Yijk = dependent 
variable, observed value for production parameter in 
treatment i, in pen j for week k; μ = overall mean; trt 
= treatment i (i = 1 to 3); pen(trt) = random effect 
(error term) of the jth pen nested within the ith treat-
ment (j = 1 to 2); week = fixed effect of week k (k = 
1 to 14); trt × week = the ith treatment in the kth 
week; and Eijk = random residual. When a period effect 
did not exist (i.e., BW), the model was as follows: Yij 
= μ + trti + penj (trti) + Eij, where Yij = dependent 
variable, treatment i, in pen j; μ = overall mean; trt = 
treatment i (i = 1 to 3); pen(trt) = random effect of 
the jth pen nested within the ith treatment (j = 1 to 
2); and Eij = random residual. Somatic cell data were 
log-transformed according to Ali and Shook (1980) for 
statistical analysis to obtain better statistical proper-
ties. When treatment effect was significant (P < 0.05), 
Tukey-Kramer test (Kramer, 1956) was used as a 
means separation procedure (P < 0.05). Health data 
were subjected to the nonparametric Wilcoxon test.
Table 2. Chemical composition of forages and experimental diet 
Nutrient
Corn  
silage
Hay crop  
silage Hay Diet
DM, % 32.30 37.40 92.7 52.5
CP, % 8.12 18.54 20.38 17.9
Soluble protein, % CP 69.40 61.60 54.6 33.8
NDF, % 38.28 48.80 44.96 30.5
Lignin, % 2.80 6.26 6.26 2.96
NFC, % 46.76 22.46 24.76 39.6
Fat, % 4.10 4.26 4.3 5.23
NEL, Mcal/kg
1 1.74 1.37 1.42 1.76
Ca, % 0.20 1.13 1.222 0.94
P, % 0.24 0.32 0.322 0.37
Mg, % 0.14 0.23 0.26 0.42
K, % 1.00 2.63 2.618 1.01
Na, % 0.00 0.02 0.0256 0.31
Zn, mg/kg 27.00 22.80 21.4 56
Cu, mg/kg 6.00 9.20 10.6 16
Mn, mg/kg 21.60 31.40 26.8 41
S, % 0.10 0.21 0.224 0.21
1NRC (2001).
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RESULTS
Production Performance
One hundred forty-two cows completed the experi-
mental period. Reasons for cow removals are listed in 
Table 3. The milk yield variables milk, 3.5% FCM, and 
ECM were higher (P < 0.01) for cows supplemented 
with YC and YC+EHY compared with control. Al-
though weekly treatment differences in milk were not 
statistically evaluated, milk yield for cows supplement-
ed with YC and YC+EHY was consistently higher over 
the initial 11 wk of the experimental period compared 
with controls (Figure 1). Those supplemented with 
YC+EHY tended to exhibited higher starting milk 
yields (wk 2–4). Fat percentage was unaffected (P > 
0.05) by treatment. Protein percentage was higher (P 
< 0.01) for cows supplemented with YC+EHY com-
pared with control; YC was not different from either 
YC+EHY or control. Weekly protein profiles (Figure 
2) illustrated that by wk 2 of experiment, cows supple-
mented with YC+EHY tended to have a consistently 
higher protein percentage than control cows. Lactose 
percentage was not affected (P > 0.05) by treatment.
Milk fat yields were higher (P < 0.01) for cows 
supplemented with YC and EHY+YC compared with 
control cows. Milk protein yields were higher (P < 
0.01) for EHY+YC compared with control cows, with 
YC cows not different from either. Figure 3 illustrates 
that protein yields tended to be higher for cows supple-
mented with YC+EHY in wk 2 through 4; thereafter 
both YC and EHY+YC were similar and tended to be 
higher than control during the remainder of the trial 
period. Treatment did not affect MUN, with all treat-
ments ranging from 11.1 to 11.4 mg/dL. Treatment did 
not affect BW or BCS (Table 4).
Health and Mastitis
Health disorders were not affected (P > 0.05) by 
treatment (Table 5). Somatic cell count during the 14-
wk experimental period was lower (P < 0.01) for cows 
supplemented with YC+EHY compared with control 
and YC (Table 6). Figure 4 illustrates that the treat-
ment effect on SCC appeared to be more pronounced 
during the second half of the trial period. During wk 
1 through 7 of trial, no differences among treatments 
were observed; however, during wk 8 to 14, cows sup-
plemented with YC+EHY had lower (P < 0.01) SCC 
compared with control and YC. New clinical cases of 
mastitis were numerically lower for cows supplemented 
with YC+EHY compared with control and YC. This 
difference was mainly exhibited during wk 8 to 14 of 
the trial.
DISCUSSION
Yeast Product Characterization
When interpreting data associated with yeast supple-
mentation, confusion often exists regarding the diver-
Table 3. The effect of yeast culture and enzymatically hydrolyzed yeast on milk composition of lactating cows 
Item
Treatment1
SEM
P-value
Control YC YC+EHY Treatment
Cows/pen2      
 Pen 1 24 23 25   
 Pen 2 23 23 23   
Milk yield, kg      
 Milk 40.5b 41.9a 42.1a 0.7 0.01
 3.5% FCM 41.6b 43.2a 43.4a 0.9 0.01
 ECM 40.9b 42.6a 42.8a 0.8 0.01
Milk composition, %      
 Fat 3.67 3.7 3.72 0.04 NS
 Protein 2.91b 2.93ab 2.98a 0.01 0.01
 Lactose 4.67 4.68 4.66 0.01 NS
 MUN, mg/dL 11.1 11.4 11.2 0.13 NS
Milk component yield, kg
 Fat 1.48b 1.55a 1.56a 0.04 0.01
 Protein 1.17b 1.21ab 1.24a 0.02 0.01
a,bMeans within the same row with different superscripts differ (P < 0.05) by Tukey-Kramer test.
1Control = standard herd fresh cow diet; YC = same as control, but with the inclusion of A-Max Yeast 
Concentrate (Vi-COR, Mason, IA) at 56 g/cow per day; YC+EHY = same as control, but with the inclusion 
of Celmanax (Vi-COR) at 28 g/cow per day.
2Reasons for cow removal from trial: Control = pen1, 1 cow: mastitis, pen 2, 2 cows: injury and ketosis. YC = 
pen 1, 2 cows: foot rot (lameness) and mastitis, pen 2: injury, ketosis/displaced abomasum; YC+EHY = pen 
2, 2 cows: ketosis and lameness.
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sity of products, their composition, processing effect 
on probable mode of action, and in the case of yeast 
cell wall, the active chemical moieties. The yeast cul-
ture used in this study was composed of dead cell walls 
(typically from strains of Saccharomyces cerevisiae), 
the medium on which yeast were grown, and a few and 
variable live yeast cells. This milieu is the active liquid 
ingredient, which is then dried onto a variable amount 
of carrier (usually a grain source), which typically dic-
tates the amount of end product fed. The addition of 
enzymatically hydrolyzed yeast cell wall (EHY) and 
yeast cell metabolites, which contain the MOS and 
β-glucan components, is added to the liquid milieu of 
the YC and dried on a carrier. This differs significantly 
from “live cell” yeast, which is required to be viable to 
exert a direct effect in the rumen, usually associated 
with oxygen scavenging or reduction of ruminal redox 
potential (Marden et al., 2008). Several processes are 
required in the development of yeast products, which 
are critical to their activity and differentiation: yeast 
strain, yeast growth media, carrier, drying process, 
and cell wall fractionation technique (i.e., mechanical, 
chemical, enzymatic).
There is conflicting information associated with yeast 
cell wall composition, exposed moieties, and their po-
tential activities. The yeast cell wall is composed of 
about 50% β-1,3 glucans, 10% β-1,6 glucans, and 40% 
mannoprotein (Lipke and Ovalle, 1998). Therefore, 
although mannose is an important high-affinity cell 
wall ligand, other molecules exist (N-acetyl galactos-
amine, d-galactosamine, d-glucosamine, d-glucose, and 
d-galactose) that may have unique binding potential 
(e.g., N-acetyl galactosamine with Cryptosporidium 
parvum (Hashim et al., 2006). In addition, the method 
of processing could dictate the degree and consistency 
of exposure associated with the various moieties. In 
the present study, yeast cell wall was prepared by en-
zymatic hydrolyzation. Enzymatic processing of yeast 
cell wall at optimal temperature, time, and pH yields 
a consistent exposure of binding sites compared with 
chemical or mechanical fractionation (Balasundaram 
and Harrison, 2006; Pitarch et al., 2008). Therefore, 
comparative study evaluation among trials in response 
to different YC or cell wall preparations requires clari-
fication and greater definition to be meaningful.
Production Performance
Literature evaluation of the effects of YC on produc-
tion performance is variable (Robinson and Garrett, 
1999; Soder and Holden, 1999). Several factors have 
been suggested that influence the response of dairy 
Figure 1. Mean weekly milk yield (data are weekly means by pen then converted to cow/d, SEM = 1.52). Control = standard herd fresh cow 
diet; yeast culture (YC) = same as control, but with the inclusion of A-Max Yeast Concentrate (Vi-COR, Mason, IA) at 56 g/cow per day; and 
yeast culture/enzymatically hydrolyzed yeast (EHY+YC) = same as control, but with the inclusion of Celmanax (Vi-COR) at 28 g/cow per day.
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cows to YC treatments, including stage of lactation, 
age, composition of the feed, and feeding strategy (Piva 
et al., 1993; Desnoyers et al., 2009). Milk production 
differences found in the present study are supported 
by findings in other studies and reviews (Shaver and 
Garrett, 1997; Nocek et al., 2003; Desnoyers et al., 
2009) with mean responses typically from 0.5 to 1.0 
kg. The lack of response to YC of fat percentage in the 
present study has been shown by others (Arambel and 
Kent, 1990), as has the lack of response for milk protein 
(Dann et al., 2000; Moallem et al., 2009); however, the 
increase in milk protein percentage associated with the 
addition of EHY has not been documented. Mode of 
action attributed to YC been shown to modify rumen 
function by stimulating fermentation (Robinson, 1997), 
increasing populations and growth rates of cellulolytic 
bacteria, and enhancing the initial digestion rate of 
forages. In continuous culture work with the YC used 
in the current study, Miller-Webster et al. (2002) dem-
onstrated no effect on NDF digestion, but showed in-
creased microbial N per kilogram of DM digested, and 
an increased protein concentration of microbes com-
pared with other YC products. The increased quantity 
and quality of microbial protein delivered postruminally 
could aid in supporting more milk protein.
A few performance studies have been conducted asso-
ciated with hydrolyzed yeast products. Calves supple-
mented with fructooligosaccharides or MOS did not 
show enhanced growth performance (Heinrichs et al., 
2003; Hill et al., 2008, 2009). Davis et al. (2002) demon-
strated improved ADG and feed efficiency for weaned 
piglets supplemented with MOS. Further justification 
for a performance response (increased milk protein) as-
sociated with EHY could be derived from modification 
to enteric microflora such that provisional nutrients are 
spared for host availability rather than bacterial utili-
zation, thus more energy and amino acid substrate are 
available for protein synthesis, as described by Ferket 
(2002) in turkeys.
SCC and Mastitis
The addition of EHY to YC clearly affected SCC and 
clinical mastitis in this study. The concept of subclini-
cal pathogenic challenges and their relation to MOS or 
β-glucan has not been extensively studied in mature 
dairy cattle. Franklin et al. (2005) supplemented dry 
cows with MOS and observed an enhancement of hu-
moral immune response to rotavirus and a tendency for 
enhanced transfer of rotavirus antibodies to calves, thus 
Figure 2. Mean weekly protein percentage (data are weekly means by pen then converted to cow/d, SEM = 0.032). Control = standard 
herd fresh cow diet; yeast culture (YC) = same as control, but with the inclusion of A-Max Yeast Concentrate (Vi-COR, Mason, IA) at 56 g/
cow per day; and yeast culture/enzymatically hydrolyzed yeast (EHY+YC) = same as control, but with the inclusion of Celmanax (Vi-COR) 
at 28 g/cow per day.
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supporting the contention of an immuno-enhancement 
process. Waller et al. (2003) infused β-1,3-glucan at 
drying off into the udders of cows infected with Staphy-
lococcus aureus and showed no therapeutic effect on 
quarters with chronic subclinical Staph. aureus mas-
titis. However, the proportion of major histocompat-
ibility complex (MHC class II) and milk lymphocytes 
tended to increase after β-glucan infusion, suggesting 
some stimulation of antigen-presenting ability.
The effect of EHY on SCC could be linked to a po-
tential immune response. Activation of the animal’s 
immune system via antigenic exposure releases an ar-
Figure 3. Mean weekly protein yield (data are weekly means by pen then converted to cow/d, SEM = 0.047). Control = standard herd 
fresh cow diet; yeast culture (YC) = same as control, but with the inclusion of A-Max Yeast Concentrate (Vi-COR, Mason, IA) at 56 g/cow 
per day; and yeast culture/enzymatically hydrolyzed yeast (EHY+YC) = same as control, but with the inclusion of Celmanax (Vi-COR) at 28 
g/cow per day.
Table 4. The effect of yeast culture and enzymatically hydrolyzed yeast supplementation on BW and BCS at 
calving and 14 wk postpartum 
Item
Treatment1
SEM
P-value
Control YC YC+EHY Treatment
Cows/pen     
 Pen 1 24 23 25  
 Pen 2 23 23 23  
BW, kg     
 Initial 701 687 705 14 NS
 Final 688 682 691 16 NS
 Change 13 5 15  
BCS     
 Initial 3.48 3.46 3.52 0.05 NS
 Final 3.28 3.29 3.32 0.07 NS
 Change 0.2 0.17 0.2  
1Control = standard herd fresh cow diet; YC = same as control, but with the inclusion of A-Max Yeast 
Concentrate (Vi-COR, Mason, IA) at 56 g/cow per day; YC+EHY = same as control, but with the inclusion 
of Celmanax (Vi-COR) at 28 g/cow per day.
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ray of cytokines that initiates a cascade of metabolic 
events, including elevated body temperature, meta-
bolic rate, gluconeogenesis, glucose oxidation, hepatic 
protein synthesis (Long, 1977; Baumann et al., 1987; 
Klasing, 1988), with a shift in hormone balance causing 
a reduction of circulating anabolic hormones (growth 
hormone, prolactin; van Deuren et al., 1992; Johnson 
and von Borell, 1994) and a concomitant increase in 
catabolic hormones (glucocorticoids; Woloski et al., 
1985). This immune system-induced shift of endocrine 
status causes depression in intake, feed efficiency, and 
tissue composition in growing chicks and pigs (Stahly 
et al., 1995; Williams et al., 1997). Sauber et al. (1999) 
demonstrated that antigen exposure (LPS of Escherich-
ia coli) to lactating sows resulted in a greater level of 
chronic immune system activation, feed intake depres-
sion, and reduced milk and milk energy in sows. Shuster 
et al. (1991) demonstrated that when cows received an 
intramammary infusion of LPS, milk and milk protein 
yield were reduced without mammary inflammation 
(indicative of mammary infection). These findings sug-
gest that a lack of lactation performance was associated 
with a physiological change causing an escape of milk 
and components through increased permeability of the 
blood–milk barrier.
Another potential effect of dietary YC+EHY supple-
mentation is the presentation of β-glucan to the γ-δ T 
cells of the intestine. Besides the gut epithelial cells, 
γ-δ T cells are among the first populations of cells to 
come into contact with pathogens presented via digesta 
in the intestine (Jutila et al., 2008). β-Glucan is now 
recognized as having an important pathogen-associated 
molecular pattern (PAMP), which primes this class of 
T cells, leading to increased proliferation and respon-
siveness to antigen or cytokines (Hedges et al., 2007). 
Bovine γ-δ T cells have been shown to respond to sev-
eral common pathogens, including Mycobacterium spp. 
(Rhodes et al., 2001), Cryptosporidium parvum (Abra-
Table 5. The effect of yeast culture and enzymatically hydrolyzed yeast supplementation on health disorders 
Item
Treatment1
Control YC YC+EHY
Cows/pen    
 Pen 1 24 23 25
 Pen 2 23 23 23
Incidence, % (no. affected)
 Twins 2.1 (1) 6.5 (3) 4.2 (2)
 Retained placenta 4.3 (2) 6.5 (3) 6.3 (3)
 Metritis 10.6 (5) 4.3 (2) 10.4 (5)
 Ketosis 8.5 (4) 8.7 (4) 6.3 (3)
 Displaced abomasum 4.3 (2) 6.5 (3) 4.2 (2)
1Control = standard herd fresh cow diet; YC = same as control, but with the inclusion of A-Max Yeast 
Concentrate (Vi-COR, Mason, IA) at 56 g/cow per day; YC+EHY = same as control, but with the inclusion 
of Celmanax (Vi-COR) at 28 g/cow per day.
Table 6. The effect of yeast culture and enzymatically hydrolyzed yeast supplementation on SCC and clinical 
mastitis 
Item
Treatment1
SEM
P-value
Control YC YC+EHY Treatment
Cows/pen      
 Pen 1 24 23 25   
 Pen 2 23 23 23   
SCC, × 1,000 cells/mL      
 1 to 14 wk postpartum 241a 258a 178b 17 0.01
 1 to 7 wk postpartum 180 209 181 16 NS
 8 to 14 wk postpartum 303a 314a 177b 19 0.01
New clinical mastitis cases      
 1 to 14 wk postpartum 12 10 5   
 1 to 7 wk postpartum 2 3 2   
 8 to 14 wk postpartum 10 7 3   
a,bMeans within the same row with different superscripts differ (P < 0.05) by Tukey-Kramer test.
1Control = standard herd fresh cow diet; YC = same as control, but with the inclusion of A-Max Yeast 
Concentrate (Vi-COR, Mason, IA) at 56 g/cow per day; YC+EHY = same as control, but with the inclusion 
of Celmanax (Vi-COR) at 28 g/cow per day.
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hamsen, 1998), Staphylococcus spp. (Fikri et al., 2001), 
and Salmonella enterica (Hedges et al., 2007), resulting 
in enhanced activity of macrophages and neutrophils 
(Born et al., 1999).
Mounting an immune response to infection can be 
energetically expensive (Demas, 2004), thus prolonged 
negative energy balance at transition could affect im-
mune competence (Waldron et al., 2003; Goff, 2006) 
and predispose cows to infectious disease after calving. 
Somatic cell count is a commonly used index of milk 
quality and a useful indicator to increase awareness of 
subclinical mastitis and its effect on production (San-
tos et al., 2004). The relation between SCC, mastitis, 
and EHY was identified in a study by Proudfoot et al. 
(2009), where cows supplemented with the EHY used in 
the present study experienced a reduction in subclinical 
mastitis and number of new clinical cases of mastitis. 
These authors reported elevated levels of IL-8, used to 
confirm the presence of an infection.
It could be speculated that the following processes 
were affecting the response to EHY in the present 
study: enteric nutrient sparing and a subclinical im-
mune response (either promotion of humoral immunity 
or prevention of a hyperimmune response); however, 
the degree of this intervention is not clearly known. 
This poses interesting avenues of research associated 
with immuno-competence, prebiotics, and enhanced 
performance.
CONCLUSIONS
Cows supplemented with YC and YC+EHY produced 
more milk, FCM, and ECM than nonsupplemented 
cows. Milk protein percentage was elevated for cows 
supplemented with YC+EHY compared with control 
cows. Milk fat yield was higher for cows supplemented 
with YC and YC+EHY compared with control cows, 
whereas protein yields were higher for YC+EHY-sup-
plemented cows compared with control cows. Somatic 
cell count was reduced for cows supplemented with 
YC+EHY; however, the response was associated more 
with wk 8 to 14 than wk 1 to 7 postpartum. Supple-
mentation of early lactation cows with YC improved 
production performance, and further performance and 
mammary gland health benefits were achieved when 
cows were additionally supplemented with EHY.
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